Task: Answer the multiple choice question.
Query: Which drug exhibits a -42.181% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a CCCn1c(/C=C/c2cc[n+](C)cc2)nc2ccccc21.[I-]
b COCCn1c(SCC(=O)NNC(=O)c2ccc(OC)c(OC)c2)nc2ccccc2c1=O
Answer: b. COCCn1c(SCC(=O)NNC(=O)c2ccc(OC)c(OC)c2)nc2ccccc2c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COCCn1c(SCC(=O)NNC(=O)c2ccc(OC)c(OC)c2)nc2ccccc2c1=O
COCCn1c(SCC(=O)NNC(=O)c2ccc(OC)c(OC)c2)nc2ccccc2c1=O
4,5-dimethoxy-N'-[2-[3-(2-methoxyethyl)-4-oxoquinazolin-2-yl]sulfanylacetyl]benzohydrazide